Riskpilot← Back to searchSign inGet full accessSYNSENTRUM AS
ASActiveOrg 943984530Prinsens Gate 39, 7011 TrondheimRetail sale of medical and orthopaedic goods · NACE 4774Est. 198722 employees
Revenue 2024
NOK 34,5M
+14% vs 2023
EBITDA margin
4.0%
+92% vs 2023
Equity ratio
19.7%
Financial strength
Net profit 2024
NOK 358K
+3% vs 2023
| Revenue | NOK 34,5M | +14% |
| EBITDA | NOK 1,4M | +92% |
| Net profit | NOK 358K | +3% |
| Total assets | NOK 8,2M | +0% |
| Equity | NOK 1,6M | +29% |
| Employees | 22 | — |
Legal name
SYNSENTRUM AS
Org number
943984530
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
2. juni 1987
Share capital
NOK 100 000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Prinsens Gate 39, 7011 Trondheim
Phone
+4773530201
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 23 474 | 27 108 | 30 034 | 30 313 | 34 525 |
| Staff expenses | −7 944 | −9 086 | −9 882 | −10 952 | −11 825 |
| EBITDA | 1 594 | 1 676 | 1 951 | 723 | 1 388 |
| Depreciation & amort. | −375 | −365 | −345 | −304 | −827 |
| EBIT | 1 219 | 1 312 | 1 606 | 420 | 562 |
| Net financials | 52 | 18 | 6 | 26 | −96 |
| Profit before tax | 1 271 | 1 330 | 1 611 | 445 | 466 |
| Tax | 281 | 294 | 356 | 98 | 108 |
| Net profit | 990 | 1 036 | 1 256 | 347 | 358 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11 182 | 7 561 | 6 806 | 8 167 | 8 171 |
| Equity | 7 299 | 1 235 | 1 241 | 1 248 | 1 606 |
| Long-term debt | 0 | 0 | 0 | 1 714 | 1 431 |
| Short-term debt | 3 883 | 6 326 | 5 566 | 5 205 | 5 134 |
| Total debt | 3 883 | 6 326 | 5 566 | 6 919 | 6 565 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
19.7%
This company
38.2%
Market median
-48% vs market
20202024
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20202024
Asset turnover
4.23×
This company
1.12×
Market median
+278% vs market
20202024
Debt / equity
4.09×
This company
0.62×
Market median
-560% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IG Deputy Member | Deputy Member | 2022 |
KW Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SYNSENTRUM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingvild Gullvåg Wiig | Deputy Member | 0 companies |
| Kjærsti Wiig | Chief Executive Officer | 0 companies |
| Tone Aavik Myhren | Board of Directors | 0 companies |
| John Eyvind Wiig | Chairman | 0 companies |
| Tone Myhren | Board of Directors | 0 companies |